An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
According to the Mayo Clinic, the BRCA test is a blood test that uses DNA analysis to identify harmful changes in one of the two breast cancer susceptibility genes (BRCA1 and BRCA2). Those who have ...
In May 2013, nearly 20 years after the discovery that mutations on the BRCA1 and BRCA2 genes could lead to a higher risk of breast and ovarian cancer, A-list Hollywood actress Angelina Jolie garnered ...
More women may benefit from gene testing for hereditary breast or ovarian cancer, especially if they’ve already survived cancer once, according to new recommendations from experts in preventive ...
The United States Preventive Services Task Force has published a statement recommending that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal ...
In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to ...
When we hear about mutations like the BRCA gene, it's usually associated with women and breast cancer screening. But researchers say not only do men get breast cancer, but the gene also shows risks ...
When we hear about gene mutations like the BRCA gene, we think of breast cancer screening in women. But, researchers say men are also at risk for the carrying the gene, which is linked to other ...
HealthDay News — Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better ...
Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...
On Tuesday, 23andMe announced it will start telling customers of its mail-in DNA-testing kit about three mutations in the breast-cancer genes BRCA1 and BRCA2—a move officially sanctioned by the Food ...
Among older women with and without breast and ovarian cancers, testing for the BRCA gene dropped precipitously between 2008 and 2018. Results from testing for BRCA1/2 pathogenic variants help to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results